Abstract VRC01 is one of the most broadly and potently neutralizing HIV-1 antibodies known—it has been shown to neutralize 91 �f the tested primary isolate Env pseudoviruses by recognizing the viral envelope glycoprotein gp120. To explore the mechanism of HIV-1 neutralization by VRC01 and thus obtain valuable information for vaccine design, we performed molecular dynamics simulations and binding free energy calculations for apo-VRC01, apo-gp120, and the gp120–VRC01 complex. For gp120, residue energy decomposition analysis showed that the hotspot residues Asn280, Lys282, Asp368, Ile371, and Asp457 are located in three primary loops, including the CD4-binding loop, loop D, and loop V5. For VRC01, the hotspot residues Trp47, Trp50, Asn58, Arg61, Gln64, Trp100, and Tyr91 mainly come from CDR2 of the heavy chain. By decomposing the binding free energy into different components, intermolecular van der Waals interactions and nonpolar solvation were found to dominate the binding process. Principal component analysis of loops D and V5, which are related to neutralization resistance, indicated that these two areas have a larger conformational space in apo-gp120 compared to bound gp120. A comparison of three representative structures from the cluster analysis of loops D and V5 indicated that changes primarily occur at the tip of loop V5, and are caused by fluctuations in the terminal Glu1 residue of the antibody. This information can be used to guide the design of vaccines and small molecule inhibitors.
van der Waals       0.999999999988745^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Van_der_Waals_force   

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

molecular dynamics            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_dynamics    

hotspot                       0.9990898900378351^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hotspot_(geology)     

conformational space          0.9999999916955176^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Configuration_space   

HIV-1                         0.999999994196969^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Subtypes_of_HIV       

HIV-1                         0.999999994196969^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Subtypes_of_HIV       

hotspot                       0.9990898900378351^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hotspot_(geology)     

free energy calculations      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gibbs_free_energy     

nonpolar                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Chemical_polarity     

energy                        0.9999999994769269^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Energy                

vaccine                       0.9045382455527023^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Vaccine               

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

small molecule                0.9999999999624833^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Molecule              

antibodies                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Antibody              

free energy                   0.9993144195871452^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Gibbs_free_energy     

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

solvation                     0.6772063159073219^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Solvation             

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

antibody                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Antibody              

cluster analysis              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cluster_analysis      

pseudoviruses                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vector_(molecular_biology)

vaccines                      0.8810005144825513^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Vaccine               

Env                           0.9996241219729013^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Env_(gene)            

envelope glycoprotein gp120   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

Principal component analysis  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Principal_component_analysis

